順天堂醫事雑誌
Online ISSN : 2188-2126
Print ISSN : 2187-9737
ISSN-L : 2187-9737
Reports
Clinical Benefit of Cancer Philosophy Clinic for Cancer Patients Using EQ-5D-5L Scores
MAYO NUNOKAWA EIICHI INADAOKIO HINO
著者情報
ジャーナル オープンアクセス

2023 年 69 巻 2 号 p. 137-143

詳細
抄録

Objective This study aims to understand the role of Cancer Philosophy Clinic activities among participants and whether participation is correlated to increase in QOL.

Materials and Methods Among the 150 Cancer Philosophy Clinics, questionnaire surveys were distributed at 28 locations that consented to participating in the study. The data was analyzed based on the respondent’s situation and health related Quality of Life (QOL) prior to and after participating in Cancer Philosophy Clinic using the EQ-5D-5L questionnaire (Japanese version) regarding health related QOL prior to and after participating in Cancer Philosophy Clinic.

Results There were more female participants than male participants; 224 and 76 respectively. 46.5%, or approximately half of all participants in the Cancer Philosophy Clinic were “cancer patients,” followed by 17.2% who were “family members of cancer patients,” 16.6% who were “not suffering from any diseases,” 11.4% who were “suffering from diseases other than cancer” and 3.2% who were classified as “other,” who were bereaved family members. 51.7% were “currently receiving treatment, “32.1% were “receiving follow-up medical care, “and 15.3% were “survivors.” There was 1 participant who commented, “refusing treatment.” Based on an evaluation of QOL using EQ-5D-5L of 184 participants who were participating in the Cancer Philosophy Clinic, an increase in overall average index value from 0.827 to 0.867 was observed after participation compared to prior participation. In particular, there was a significant improvement in “pain/discomfort,” “anxiety/depression.

Conclusions Cancer Philosophy clinic has been found important role in encouraging existing shift.

著者関連情報
© 2023 The Juntendo Medical Society. This is an open access article distributed under the terms of Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original source is properly credited.

This article is licensed under a Creative Commons [Attribution 4.0 International] license.
https://creativecommons.org/licenses/by/4.0/
前の記事 次の記事
feedback
Top